PI Warkentin

962 total citations
28 papers, 718 citations indexed

About

PI Warkentin is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, PI Warkentin has authored 28 papers receiving a total of 718 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 14 papers in Oncology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in PI Warkentin's work include Hematopoietic Stem Cell Transplantation (15 papers), Acute Lymphoblastic Leukemia research (6 papers) and Acute Myeloid Leukemia Research (5 papers). PI Warkentin is often cited by papers focused on Hematopoietic Stem Cell Transplantation (15 papers), Acute Lymphoblastic Leukemia research (6 papers) and Acute Myeloid Leukemia Research (5 papers). PI Warkentin collaborates with scholars based in United States. PI Warkentin's co-authors include Anne Kessinger, PF Coccia, Sarah E. Strandjord, RH Herzig, NK Cheung, J. McCullough, Larry C. Lasky, John H. Kersey, N. K. C. Ramsay and J. O. Armitage and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

PI Warkentin

27 papers receiving 677 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
PI Warkentin 589 201 175 139 137 28 718
Robert Witherspoon 488 0.8× 219 1.1× 104 0.6× 144 1.0× 229 1.7× 16 727
V Shepherd 565 1.0× 214 1.1× 88 0.5× 121 0.9× 209 1.5× 21 747
G Dart 452 0.8× 259 1.3× 66 0.4× 118 0.8× 102 0.7× 19 661
James Gajewski 635 1.1× 246 1.2× 154 0.9× 139 1.0× 338 2.5× 13 852
Martine Delain 560 1.0× 266 1.3× 243 1.4× 134 1.0× 88 0.6× 35 893
H. Lumley 386 0.7× 180 0.9× 112 0.6× 101 0.7× 136 1.0× 10 568
M Kasai 431 0.7× 138 0.7× 89 0.5× 119 0.9× 244 1.8× 41 716
A Ferrant 342 0.6× 175 0.9× 130 0.7× 189 1.4× 60 0.4× 27 624
P. Dyson 625 1.1× 312 1.6× 52 0.3× 127 0.9× 245 1.8× 19 850
Jean Pierre Jouet 731 1.2× 164 0.8× 146 0.8× 356 2.6× 124 0.9× 24 904

Countries citing papers authored by PI Warkentin

Since Specialization
Citations

This map shows the geographic impact of PI Warkentin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by PI Warkentin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites PI Warkentin more than expected).

Fields of papers citing papers by PI Warkentin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by PI Warkentin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by PI Warkentin. The network helps show where PI Warkentin may publish in the future.

Co-authorship network of co-authors of PI Warkentin

This figure shows the co-authorship network connecting the top 25 collaborators of PI Warkentin. A scholar is included among the top collaborators of PI Warkentin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with PI Warkentin. PI Warkentin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reed, Eddie, Kenneth H. Cowan, PI Warkentin, et al.. (2009). Autologous dendritic cell vaccine directed at wild type p53 in patients with high-risk breast cancer treated with adjuvant chemotherapy.. Cancer Research. 69(2_Supplement). 2152–2152. 2 indexed citations
2.
Warkentin, PI. (2003). Voluntary accreditation of cellular therapies: Foundation for the Accreditation of Cellular Therapy (FACT). Cytotherapy. 5(4). 299–305. 28 indexed citations
3.
Varney, Michelle L., et al.. (1998). Comparison of monocyte-dependent T cell inhibitory activity in GM-CSF vs G-CSF mobilized PSC products. Bone Marrow Transplantation. 23(1). 63–69. 35 indexed citations
4.
Bishop, Michael R., Stefano Tarantolo, John D. Jackson, et al.. (1997). Allogeneic-blood stem-cell collection following mobilization with low-dose granulocyte colony-stimulating factor.. Journal of Clinical Oncology. 15(4). 1601–1607. 24 indexed citations
6.
Bishop, Michael R., John D. Jackson, Kim Schmit-Pokorny, et al.. (1996). Phase I trial of recombinant fusion protein PIXY321 for mobilization of peripheral-blood cells.. Journal of Clinical Oncology. 14(9). 2521–2526. 17 indexed citations
7.
Kessinger, Anne, Michael R. Bishop, JR Anderson, et al.. (1995). Comparison of Subcutaneous and Intravenous Administration of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor for Peripheral Blood Stem Cell Mobilization. Journal of Hematotherapy. 4(2). 81–84. 5 indexed citations
8.
Phillips, Glenn, Jamés O. Armitage, SI Bearman, et al.. (1995). American Society for Blood and Marrow Transplantation guidelines for clinical centers.. PubMed. 1(1). 54–5. 3 indexed citations
10.
Bishop, Michael R., PI Warkentin, John D. Jackson, et al.. (1994). Antisense oligonucleotide OL (1) p53 for in vitro purging of autologous bone marrow in acute myelogenous leukemia.. PubMed. 389. 183–7. 6 indexed citations
11.
Warkentin, PI, et al.. (1994). Comparison of sterility profiles from slaughterhouse versus surgically removed pancreata for islet isolation with a new semiclosed method involving the COBE 2991.. PubMed. 26(2). 625–7. 1 indexed citations
12.
Warkentin, PI, DD Weisenburger, JM Vose, et al.. (1992). Bone marrow transplantation for peripheral T-cell lymphoma in children and adolescents. Blood. 80(11). 2938–2942. 19 indexed citations
13.
Kessinger, Anne, David M. Smith, Sarah E. Strandjord, et al.. (1989). Allogeneic transplantation of blood-derived, T cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia.. PubMed. 4(6). 643–6. 112 indexed citations
14.
Strandjord, Sarah E., Wendy L. Golden, M. Simón, et al.. (1989). Origin of leukemic relapse after bone marrow transplantation: comparison of cytogenetic and molecular analyses. Blood. 73(7). 2033–2040. 21 indexed citations
16.
Strandjord, Sarah E., Ulla M. Saarinen, PI Warkentin, et al.. (1988). In vitro treatment of autologous bone marrow for neuroblastoma patients with anti GD2 monoclonal antibody and human complement: a pilot study.. PubMed. 271. 237–48. 6 indexed citations
17.
Herzig, RH, P. Coccia, Hillard M. Lazarus, et al.. (1985). Bone marrow transplantation for acute leukemia and lymphoma with high-dose cytosine arabinoside and total body irradiation.. PubMed. 12(2 Suppl 1). 139–40. 21 indexed citations
18.
Hughes, Christopher B., et al.. (1985). Oropharyngeal Candida prophylaxis in pediatric bone marrow transplant patients.. PubMed. 7(1). 82–6. 14 indexed citations
19.
McCullough, J., Larry C. Lasky, & PI Warkentin. (1984). Role of the blood bank in bone marrow transplantation.. PubMed. 149. 379–412. 3 indexed citations
20.
Warkentin, PI, et al.. (1978). Acute hepatocellular injury after high dose methotrexate (MTX) infusions. 19. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026